sodium salicylate has been researched along with leupeptins in 3 studies
| Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (leupeptins) | Trials (leupeptins) | Recent Studies (post-2010) (leupeptins) |
|---|---|---|---|---|---|
| 2,031 | 50 | 171 | 3,891 | 4 | 1,106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McEver, RP; Pan, J; Xia, L; Yao, L | 1 |
| Gallois, C; Habib, A; Lotersztajn, S; Maclouf, J; Mallat, A; Moulin, S; Tao, J | 1 |
| Ip, WK; Lam, CW; Wong, CK; Zhang, JP | 1 |
3 other study(ies) available for sodium salicylate and leupeptins
| Article | Year |
|---|---|
A proteasome inhibitor, an antioxidant, or a salicylate, but not a glucocorticoid, blocks constitutive and cytokine-inducible expression of P-selectin in human endothelial cells.
Topics: Animals; Antioxidants; Aorta; Cattle; Cells, Cultured; Cysteine Proteinase Inhibitors; Cytokines; Dexamethasone; Endothelium, Vascular; Gene Expression; Humans; Interleukin-4; Leupeptins; NF-kappa B; Oncostatin M; P-Selectin; Peptides; Pyrrolidines; Sodium Salicylate; Thiocarbamates; Umbilical Veins | 1998 |
Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2.
Topics: Adipocytes; Antineoplastic Agents; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dexamethasone; Dimerization; DNA-Binding Proteins; Endothelin-1; Fibroblasts; Humans; I-kappa B Proteins; Isoenzymes; Leupeptins; Liver; Membrane Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Receptor, Endothelin B; Receptors, Endothelin; Sodium Salicylate; Tumor Necrosis Factor-alpha; Up-Regulation; Viper Venoms | 1998 |
Activation of p38 mitogen-activated protein kinase and nuclear factor-kappaB in tumour necrosis factor-induced eotaxin release of human eosinophils.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Chemokine CCL11; Chemokines, CC; Chemotactic Factors, Eosinophil; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Enzyme Activation; Eosinophils; Gene Expression Profiling; Humans; I-kappa B Proteins; Imidazoles; Leupeptins; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Pyridines; Sodium Salicylate; Tumor Necrosis Factor-alpha | 2002 |